Status:
COMPLETED
Effects of Melatonin as a Novel Antioxidant and Free Radicals Scavenger in Neonatal Sepsis
Lead Sponsor:
Mohamed Hussein Metwally
Conditions:
Neonatal Sepsis
Eligibility:
All Genders
1-28 years
Phase:
PHASE1
PHASE2
Brief Summary
Assess the efficacy of melatonin as an adjuvant in the treatment of free radical disease in septic preterms receiving melatonin compared to those on conventional treatment through measuring the level ...
Detailed Description
This is a randomized controlled trial. It will be provisionally conducted on 55 neonates admitted to the neonatal intensive care units (NICUs) of Ain Shams University Hospitals, Cairo, Egypt. Inclusi...
Eligibility Criteria
Inclusion
- Preterm infants ( less than 37 weeks gestational age). Evidence of neonatal sepsis
Exclusion
- Infants with hypoxic ischemic encephalopath Infants on nothing per os. Infants with high oxygen needs either on invasive or non-invasive mechanical ventilation.
Key Trial Info
Start Date :
November 26 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2017
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT03295162
Start Date
November 26 2015
End Date
September 1 2017
Last Update
September 27 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.